Anthropometric Measurements as Predictors of Low Birth Weight Among Tanzanian Neonates: A Hospital-Based Study
November 7, 2025
Brand Name :
No Data Available.
Synonyms :
pentoxyverine
Class :
Cough suppressants
Dosage Forms & StrengthsÂ
SuspensionÂ
30mg/5mlÂ
Take an oral dose of 5 to 10 ml in each 12 hours
Dosage Forms & StrengthsÂ
SuspensionÂ
30mg/5mlÂ
for 2 to 5 years old:
Take an oral dose of 1.25 to 2.5 ml in each 12 hours
for 6 to 11 years old:
Take an oral dose of 2.5to 5 ml in each 12 hours
for >12 years old:
Take an oral dose of 5 to 10 ml in each 12 hours
Refer to adult dosingÂ
pentoxyverine: it may increase the risk of methemoglobinemia agents
pentoxyverine: it may increase the risk of methemoglobinemia agents
pentoxyverine: it may increase the risk of methemoglobinemia agents
pentoxyverine: it may increase the risk of methemoglobinemia agents
pentoxyverine: it may increase the risk of methemoglobinemia agents
Actions and SpectrumÂ
pentoxyverine exerts its cough suppressant action by depressing the cough reflex centre in the brainstem. It does this by reducing the sensitivity of the sensory receptors in the airways and lungs that trigger the cough reflex.
Frequency not defined Â
Slight drowsinessÂ
Minor gastric disorders Â
Skin rashÂ
Black Box WarningÂ
NoneÂ
Contraindication/Caution:Â
Contraindication:Â
Caution:Â
Pregnancy consideration:Â
Pregnancy category: N/AÂ
Lactation: Excretion into human milk is unknown Â
Pregnancy Categories:        Â
Category A: well-controlled and Satisfactory studies show no risk to the fetus in the first or later trimester.Â
Category B: there was no evidence of risk to the fetus in animal studies, and there were not enough studies on pregnant women. Â
Category C: there was evidence of risk of adverse effects in animal reproduction studies, and no adequate evidence in human studies must take care of potential risks in pregnant women.Â
Category D: adequate data with sufficient evidence of human fetal risk from various platforms, but despite the potential risk, and used only in emergency cases for potential benefits.Â
Category X: Drugs listed in this category outweigh the risks over benefits. Hence these categories of drugs need to be avoided by pregnant women.Â
Category N: There is no data available for the drug under this category.Â
Pharmacology Â
pentoxyverine has anticholinergic properties, meaning it inhibits the activity of acetylcholine, a neurotransmitter. It can help reduce the activity of the parasympathetic nervous system, which is involved in stimulating bronchoconstriction and increased mucus secretion in the airways.Â
PharmacodynamicsÂ
pentoxyverine has mild local anesthetic effects on the mucous membranes of the respiratory tract. This can help alleviate irritation and sensitivity of the cough receptors in the airways, leading to decreased coughing.Â
PharmacokineticsÂ
Absorption  Â
pentoxyverine is absorbed from the gastrointestinal tract into the bloodstream.Â
DistributionÂ
pentoxyverine is distributed throughout the body. Â
MetabolismÂ
pentoxyverine undergoes metabolism in the liver. Â
Elimination and excretionÂ
pentoxyverine is excreted through the kidneys.Â
AdministrationÂ
pentoxyverine is administered orally and available in the form of tablet and suspension.Â
Patient information leafletÂ
Generic Name: pentoxyverineÂ
Why do we use pentoxyverine?Â
pentoxyverine is mainly used to alleviate coughing associated with various respiratory conditions.  Â
pentoxyverine is used as cough suppressant to relieve cough caused by the common cold, flu, bronchitis, and sinusitis.Â